Doctors warn surgery risks rise for patients using weight loss injections
Australian and New Zealand anaesthetists warn that patients using GLP-1 drugs or unapproved peptides face serious surgical risks if they do not disclose their medication use.
Study shows high aspiration risk
A new study found an 11-fold increase in the risk of aspiration for users of GLP-1 medications under general anaesthetic. Pulmonary aspiration occurs when food or liquid enters the airways and lungs, which experts describe as a potentially fatal event.
Patients often hide medication use
Some individuals fail to declare their use of these drugs because they feel embarrassed or fear being judged by medical staff. Tanya Selak from the Australian and New Zealand College of Anaesthetists noted that weight stigma drives patients to conceal private details about their treatment.
Standard fasting rules apply
National guidelines currently recommend that patients on these drugs take clear fluids for 24 hours before a standard six-hour fast prior to surgery. Doctors state that failing to follow these protocols or hiding medication use could lead to serious consequences during operations.
Reported by one outlet
Only one outlet has published this. Nothing here has been checked against a second report, so read it as that outlet's account and follow the link below for the original.
Reported by
1 independent outlet. Headline as published. Links open the original report.